Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-10-062171
Filing Date
2010-12-10
Accepted
2010-12-10 16:54:00
Documents
1
Period of Report
2010-10-28

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4498
  Complete submission text file 0001104659-10-062171.txt   6435
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 8479376100
ABBOTT LABORATORIES (Reporting) CIK: 0000001800 (see all company filings)

State of Incorp.: IL | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33054 | Film No.: 101245548
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 2068380500
Trubion Pharmaceuticals, Inc (Issuer) CIK: 0001298521 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations